Dr Christopher Cawthorne C.Cawthorne@hull.ac.uk
Development of a multipurpose small animal phantom for pre-clinical radiotherapy studies
People Involved
Dr Vicky Green V.L.Green@hull.ac.uk
Post-doctoral Research Scientist
Professor John Greenman J.Greenman@hull.ac.uk
Professor of Tumour Immunology
Project Description
The project aims to both reduce the total number of animals used for preclinical radiotherapy experiments whilst concurrently increasing the accuracy of such investigations in order to maximise their clinical impact. This will be achieved through the development of a multipurpose small animal phantom and standardized dosimetry procedures aiming to reduce dose uncertainties in preclinical investigations (due to the steep dose responses, a 5% improvement in dose uncertainty would roughly halve the number of animal required to achieve the same statistical relevance). Inclusion of a bespoke microfluidic device, for human tissue culture, will also offer an alternative in vivo-like option for radiation-drug synergistic studies, standardizing radiobiological experiments to be undertaken by new groups using human tissue biopsies. The proposed phantom will scale down established medical physics methodologies to provide confidence and accuracy for pre-clinical studies to match current clinical practice. The project addresses pre-clinical issues identified by translational research groups, the funding bodies and the clinical community opening up new business opportunities for dosimetry services.
| Type of Project | Project |
|---|---|
| Status | Project Complete |
| Funder(s) | Innovate UK |
| Value | £193,197.00 |
| Project Dates | Apr 1, 2016 - Mar 31, 2019 |
| Partner Organisations | Xstrahl Ltd National Physical Laboratory |
You might also like
Blood test for clinical therapy guidance of non-small cell lung cancer patients Jan 1, 2017 - Oct 31, 2022
Lung cancer is the most common cancer worldwide. NSCLC alone make up about 75% of all lung cancers and most hospitals currently test all NSCLC patients for EGFR mutations (pharmacogenomics) for treatment decision (personalised medicine) – i.e., patie...
Read More about Blood test for clinical therapy guidance of non-small cell lung cancer patients.
The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture. Jun 1, 2017 - May 31, 2018
Graves’ disease (GD) affects approximately 2% of adult women. Current treatments for GD include anti-thyroid drugs, radioiodine therapy and surgery, of which none tackle the underlying pathogenic process. Immunosuppressive agents are therefore of gro...
Read More about The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture..
Positron Emission Tomography research Mar 1, 2016 - Feb 28, 2017
The Hull-Norwich Gut-Brian Study May 31, 2016 - Jun 30, 2018
Objective To obtain mechanistic insights into how resident commensal gut bacteria (the microbiota) influences host physiology and in particular brain function and host behaviour. The focus is on identifying the pathways and molecules originating from...
Read More about The Hull-Norwich Gut-Brian Study.
Lab on a Chip NC3Rs Engagement Award Aug 15, 2016 - Aug 14, 2017
This project will deliver a programme of public engagement with innovative hands-on activities in the area of tissue/organ-on-a-chip which are emerging as life-like models to reduce and replace animal testing to school children and the general public...
Read More about Lab on a Chip NC3Rs Engagement Award.